We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+0.8%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$796M
AUM Growth
-$185M
Cap. Flow
-$163M
Cap. Flow %
-20.42%
Top 10 Hldgs %
3.37%
Holding
1,987
New
622
Increased
338
Reduced
393
Closed
624

Top Sells

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$5.34M
2
MSFT icon
Microsoft
MSFT
+$5.22M
3
OPLN
Openlane
OPLN
+$4.6M
4
AAPL icon
Apple
AAPL
+$4.51M
5
HRI icon
Herc Holdings
HRI
+$4.09M

Sector Composition

Rank Sector Weight
1 Healthcare 16.45%
2 Industrials 15.7%
3 Technology 14.88%
4 Consumer Discretionary 11.13%
5 Financials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATOM icon
1401
Atomera
ATOM
$214M
-37,043
Closed -$855K
ATR icon
1402
AptarGroup
ATR
$8.61B
-17,723
Closed -$2.12M
ATXS
1403
DELISTED
Astria Therapeutics
ATXS
-24,996
Closed -$221K
AUPH icon
1404
Aurinia Pharmaceuticals
AUPH
$2.11B
-22,904
Closed -$507K
AVXL icon
1405
Anavex Life Sciences
AVXL
$310M
-30,301
Closed -$544K
AVY icon
1406
Avery Dennison
AVY
$13.4B
-1,683
Closed -$349K
AWK icon
1407
American Water Works
AWK
$26.9B
-1,678
Closed -$284K
DCH
1408
Dauch Corp
DCH
$1.51B
-16,710
Closed -$147K
BANR icon
1409
Banner Corp
BANR
$2.4B
-6,450
Closed -$356K
BCLI
1410
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
-11,470
Closed -$568K
BCRX icon
1411
BioCryst Pharmaceuticals
BCRX
$2.4B
-41,116
Closed -$591K
BDTX icon
1412
Black Diamond Therapeutics
BDTX
$112M
-69,299
Closed -$586K
BF.B icon
1413
Brown-Forman Class B
BF.B
$13.1B
-22,921
Closed -$1.54M
BHC icon
1414
Bausch Health
BHC
$2.34B
-9,227
Closed -$257K
BHE icon
1415
Benchmark Electronics
BHE
$2.96B
-30,785
Closed -$822K
BIDU icon
1416
Baidu
BIDU
$37.2B
-2,105
Closed -$324K
BILL icon
1417
BILL Holdings
BILL
$4.78B
-3,994
Closed -$1.07M
BIPC icon
1418
Brookfield Infrastructure
BIPC
$4.85B
-5,078
Closed -$203K
BKNG icon
1419
Booking.com
BKNG
$161B
-3,625
Closed -$344K
BLD
1420
DELISTED
TopBuild
BLD
-2,183
Closed -$447K
BMRN icon
1421
BioMarin Pharmaceuticals
BMRN
$12.4B
-10,780
Closed -$833K
BPMC
1422
DELISTED
Blueprint Medicines
BPMC
-4,908
Closed -$505K
BR icon
1423
Broadridge
BR
$19B
-1,866
Closed -$311K
BRC icon
1424
Brady Corp
BRC
$4.57B
-20,648
Closed -$1.05M
BRO icon
1425
Brown & Brown
BRO
$23.9B
-4,204
Closed -$233K

Similar funds

GSA Capital Partners's Q4 2021 Portfolio in Review

As of Q4 2021, GSA Capital Partners held 1,987 positions worth $796M, down 19% from $982M the previous quarter. Its ten largest holdings account for 3.4% of the portfolio.

GSA Capital Partners withdrew a net $163M in Q4 2021, closing 624 positions and reducing 393 holdings. Its most notable exit was Morgan Stanley, an estimated $5.34M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.

Against the trend, GSA Capital Partners opened a new position in Genius Sports worth $2.45M.

  • GSA Capital Partners's largest Q4 2021 buy was Genius Sports: 322,717 shares worth $2.45M.
  • GSA Capital Partners added most to State Street Consumer Staples Select Sector SPDR ETF in Q4 2021, an estimated $2.43M increase.
  • GSA Capital Partners's biggest Q4 2021 reduction was Microsoft, cutting an estimated $5.22M.
  • GSA Capital Partners fully exited Morgan Stanley in Q4 2021, selling an estimated $5.34M.
  • GSA Capital Partners's ten largest holdings make up 3.4% of its $796M portfolio in Q4 2021.
  • GSA Capital Partners opened 622 new positions and closed 624 in Q4 2021.
  • GSA Capital Partners's portfolio value fell 19% quarter-over-quarter to $796M.

Based on GSA Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.